How do companies that have struck MFN deals see Europe?
The CEOs of three companies have sounded warnings to the region
News
News
National Framework for Plasma-Derived Therapies
SFEE | October 2025
The pharmaceutical market in Greece: Facts and Figures 2024
IOBE-SFEE Press Release
Greek Innovation Fund an important step, but a limited one, says industry
Statement by Michael Himonas, SFEE General Manager, on the Innovation Fund / Transitional Reimbursement Scheme – EURACTIV
The social initiative “proSfEEroume” in Mytilene
Press Release SFEE-HRC
SFEE: In Support of the WHA Resolution on Rare Diseases
SFEE Press Release
